Therapeutic indications during acute episodes of multiple sclerosis;Indications thérapeutiques lors des poussées de sclérose en plaques

Revue Neurologique

Volumn 157, Issue 8-9 II, 2001, Pages 988-995

  Brochet, B ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; METHYLPREDNISOLONE; PLACEBO;

ACUTE DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DISABILITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MEGADOSE; FOLLOW UP; HUMAN; MULTIPLE SCLEROSIS; OPTIC NERVE DISEASE; RELAPSE; STEROID THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; FOLLOW-UP STUDIES; HUMANS; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0034795070     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Methylprednisolone in multiple sclerosis: A comparison of oral with intravenous therapy at equivalent high dose
2. Glucocorticosteroid therapy for multiple sclerosis: A critical review
3. Intravenous methylprednisolone for multiple sclerosis in relapse
4. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis
5. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis
6. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis
7. The optic neuritis treatment trial: Three-year follow-up results
8. Sudden death after methylprednisolone pulse therapy
9. A trial of corticotrophin gelatin injection in acute optic neuritis
10. Aspects cliniques, physiopathologiques et thérapeutiques de la sclérose en plaques
11. Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis
12. Steroids for multiple sclerosis and optic neuritis: A meta-analysis of randomized controlled clinical trials
13. High dose intravenous methylprednisolone in the treatment of multiple sclerosis
14. The effect of high dose intravenous methylprednisolone on event-related potentials in patients with multiple sclerosis
15. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis
16. Anaphylaxis after intravenous methylprednisolone administration
17. The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis
18. Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis
19. Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis
20. Studies on natural history of multiple sclerosis. 4. Clinical features of the onset bout
21. Studies on natural history of multiple sclerosis. 7. Correlates of clinical change in an early bout
22. A Phase II Trial of Anti-CD11/CD18 Monoclonal Antibody in Acute Exacerbations of Multiple Sclerosis
23. Methylprednisolone therapy in multiple sclerosis: A profile of adverse effects
24. Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosis
25. Long term treatment of multiple sclerosis with corticotrophin
26. Multiple sclerosis: Treatment of acute excerbations with corticotrophin (ACTH)
27. A double blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis. I Clinical effects
28. Fatal arrythmia after pulse methylprednisolone therapy
29. Randomized trial comparing two different high doses of methylprednisolone in MS: A clinical and MRI study
30. Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis
31. Treatment of acute retrobulbar neuritis with corticotrophin
32. Treatment of retrobulbar neuritis with corticotrophin
33. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo
34. Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis
35. Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS
36. A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis
37. The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis
38. Use of an oral corticosteroid in the treatment of multiple sclerosis
39. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease